Omer Jamy
University of Alabama at Birmingham
H-index: 13
North America-United States
Top articles of Omer Jamy
Treatment-Free Remission in Chronic Myeloid Leukemia
2021/10/28
Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia
Leukemia Research
2024/2/28
Pankit Vachhani
H-Index: 10
Omer Jamy
H-Index: 8
Radiation-free conditioning in acute lymphoblastic leukemia: is it time?
Chinese Clinical Oncology
2024/2/4
Razan Mohty
H-Index: 4
Omer Jamy
H-Index: 8
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Haematologica
2023/7/7
Goals, preferences, and concerns of patients with acute myeloid leukemia at time of treatment decision
Journal of Geriatric Oncology
2023/7/1
Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia
Bone Marrow Transplantation
2023/7
Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis
Transplantation and cellular therapy
2022/5/1
HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice
Blood
2023/11/28
The COVID-19 pandemic and in-person visit rate disruptions among patients with hematologic neoplasms in the US in 2020 to 2021
JAMA Network Open
2023/6/1
Exploring Symptom Burden, Treatment Bother, Physical Function, and Quality of Life By Frailty Status in Patients with Multiple Myeloma
Blood
2023/11/28
Omer Jamy
H-Index: 8
Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies
Blood
2023/11/28
Antonio Di Stasi
H-Index: 16
Omer Jamy
H-Index: 8
Outcomes of 3-versus 5-day administration schedule of consolidation cytarabine in adults with acute myeloid leukemia (AML).
2023/6/1
Predictors of early port infection in adult patients with acute myeloid leukemia.
2023/6/1
Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis-a Quality of Life Evaluation
Blood
2023/11/28
Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia
Blood
2023/11/28
Pankit Vachhani
H-Index: 10
Omer Jamy
H-Index: 8
A randomized, open-label study of the efficacy and safety of galinpepimut-S (GPS) maintenance monotherapy compared to investigator's choice of best available therapy (BAT) in …
2023/6/1
HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice
Blood
2023/11/28
Real-World Evidence of Treatment-Free Remission in Chronic Myeloid Leukemia at an Academic Center in the Deep South
Blood
2023/11/28
Pankit Vachhani
H-Index: 10
Omer Jamy
H-Index: 8
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Leukemia
2023/5
Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation
2023/3
